Phages against Noncapsulated Klebsiella pneumoniae: Broader Host range, Slower Resistance.

Klebsiella pneumoniae antimicrobial resistance bacteriophage therapy bacteriophage-bacteria interactions bacteriophages genomics host range in vivo noncapsulated mutants phage resistance phage therapy phage-bacteria interactions

Journal

Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614

Informations de publication

Date de publication:
17 08 2023
Historique:
medline: 21 8 2023
pubmed: 20 6 2023
entrez: 20 6 2023
Statut: ppublish

Résumé

Klebsiella pneumoniae (Kp), a human gut colonizer and opportunistic pathogen, is a major contributor to the global burden of antimicrobial resistance. Virulent bacteriophages represent promising agents for decolonization and therapy. However, the majority of anti-Kp phages that have been isolated thus far are highly specific to unique capsular types (anti-K phages), which is a major limitation to phage therapy prospects due to the highly polymorphic capsule of Kp. Here, we report on an original anti-Kp phage isolation strategy, using capsule-deficient Kp mutants as hosts (anti-K

Identifiants

pubmed: 37338376
doi: 10.1128/spectrum.04812-22
pmc: PMC10433977
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0481222

Déclaration de conflit d'intérêts

The authors declare a conflict of interest. The authors Brisse and Lourenço have submitted a patent application related to this work: EP22306064.1 “Bacteriophage(s) Targeting Capsular Deficient

Références

ISME J. 2020 Dec;14(12):2980-2996
pubmed: 32732904
Proc Biol Sci. 2012 May 22;279(1735):1896-903
pubmed: 22171085
PeerJ. 2015 Jul 28;3:e1061
pubmed: 26246963
mSystems. 2020 Mar 24;5(2):
pubmed: 32209717
J Biol Chem. 2002 Jul 12;277(28):25070-81
pubmed: 11986326
Commun Biol. 2022 Jan 13;5(1):48
pubmed: 35027665
Environ Microbiol. 2021 Dec;23(12):7723-7740
pubmed: 33754440
Genome Announc. 2015 Oct 01;3(5):
pubmed: 26430050
Microb Genom. 2016 Aug 25;2(8):e000073
pubmed: 28348868
Nat Commun. 2021 Jul 7;12(1):4188
pubmed: 34234121
Sci Rep. 2015 Feb 10;5:8365
pubmed: 25666585
Antimicrob Agents Chemother. 2011 Apr;55(4):1358-65
pubmed: 21245450
J Biol Chem. 1992 Mar 25;267(9):5751-4
pubmed: 1556094
PLoS One. 2013 Apr 09;8(4):e60717
pubmed: 23593293
Microorganisms. 2020 Mar 07;8(3):
pubmed: 32156053
Cell Host Microbe. 2019 Jun 12;25(6):803-814.e5
pubmed: 31175044
Curr Protoc Bioinformatics. 2020 Jun;70(1):e102
pubmed: 32559359
PLoS Genet. 2019 Apr 15;15(4):e1008114
pubmed: 30986243
J Infect Dis. 2014 Dec 1;210(11):1734-44
pubmed: 25001459
Res Microbiol. 2019 Apr - May;170(3):165-170
pubmed: 30817987
Appl Microbiol Biotechnol. 2017 Jan;101(2):673-684
pubmed: 27766357
mBio. 2020 Jan 28;11(1):
pubmed: 31992617
Cell Host Microbe. 2020 Sep 9;28(3):390-401.e5
pubmed: 32615090
Genome Announc. 2017 Feb 23;5(8):
pubmed: 28232430
Cell Host Microbe. 2022 Apr 13;30(4):556-569.e5
pubmed: 35421351
Evid Based Nurs. 2023 Jul 27;:
pubmed: 37500506
Environ Microbiol. 2012 Aug;14(8):1844-54
pubmed: 22118225
Viruses. 2021 Dec 21;14(1):
pubmed: 35062209
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
PLoS Biol. 2021 Jul 6;19(7):e3001276
pubmed: 34228700
Microorganisms. 2021 Mar 21;9(3):
pubmed: 33801047
PeerJ. 2021 May 6;9:e11396
pubmed: 33996289
Nat Rev Microbiol. 2017 Jul;15(7):397-408
pubmed: 28461690
Nat Microbiol. 2016 Nov 21;2:16215
pubmed: 27869789
Proc Biol Sci. 2021 Mar 10;288(1946):20202876
pubmed: 33653142
Mol Microbiol. 2020 May;113(5):889-905
pubmed: 31912541
Mol Biol Evol. 2022 Jul 2;39(7):
pubmed: 35700230
Nucleic Acids Res. 2019 Jul 2;47(W1):W256-W259
pubmed: 30931475
BMC Microbiol. 2020 Oct 27;20(1):325
pubmed: 33109078
BMC Genomics. 2008 Feb 08;9:75
pubmed: 18261238
Front Microbiol. 2021 Aug 09;12:669618
pubmed: 34434173
Antibiotics (Basel). 2021 Jul 22;10(8):
pubmed: 34438943
J Antimicrob Chemother. 2020 Dec 1;75(12):3491-3500
pubmed: 32780112
Sci Rep. 2017 Aug 15;7(1):8292
pubmed: 28811656
Microb Genom. 2022 Mar;8(3):
pubmed: 35311639
Nucleic Acids Res. 2011 Jan;39(Database issue):D583-90
pubmed: 21097882
J Clin Microbiol. 2018 May 25;56(6):
pubmed: 29618504
J Virol. 2017 Feb 28;91(6):
pubmed: 28077636
Nat Med. 2020 May;26(5):705-711
pubmed: 32284589
Cell Rep. 2023 Feb 28;42(2):112048
pubmed: 36753420
Genome Announc. 2015 Oct 01;3(5):
pubmed: 26430049
Emerg Infect Dis. 2014 Nov;20(11):1812-20
pubmed: 25341126
DNA Res. 2021 Aug 25;28(4):
pubmed: 34390569
Annu Rev Virol. 2021 Sep 29;8(1):95-113
pubmed: 34255542
Microb Genom. 2022 Jan;8(1):
pubmed: 35019836
Microbiology (Reading). 2011 Dec;157(Pt 12):3446-3457
pubmed: 21964731
Front Microbiol. 2019 May 28;10:1189
pubmed: 31191500
Nucleic Acids Res. 2019 Jan 8;47(D1):D687-D692
pubmed: 30395255
Methods Mol Biol. 2009;502:3-9
pubmed: 19082547
Cell Host Microbe. 2017 Jul 12;22(1):38-47.e4
pubmed: 28704651
BMC Microbiol. 2021 Jun 21;21(1):186
pubmed: 34154528
Cell Host Microbe. 2017 Dec 13;22(6):801-808.e3
pubmed: 29174401
Phage (New Rochelle). 2021 Mar 1;2(1):26-42
pubmed: 33796863

Auteurs

Marta Lourenço (M)

Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France.

Lisa Osbelt (L)

Department of Microbial Immune Regulation, Helmholtz Center for Infection Research, Braunschweig, Germany.
German Center for Infection Research (DZIF), partner site Hannover-Braunschweig, Braunschweig, Germany.

Virginie Passet (V)

Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France.

François Gravey (F)

Dynamycure Inserm UM1311 Normandie Univ, UNICAEN, UNIROUEN, Caen, France.

Daniela Megrian (D)

Unité de Microbiologie Structurale, Institut Pasteur, CNRS UMR 3528, Université Paris Cité, Paris, France.

Till Strowig (T)

Department of Microbial Immune Regulation, Helmholtz Center for Infection Research, Braunschweig, Germany.
German Center for Infection Research (DZIF), partner site Hannover-Braunschweig, Braunschweig, Germany.

Carla Rodrigues (C)

Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France.

Sylvain Brisse (S)

Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH